Evotec SE (EVO) is the 45th largest of 96 Contract Research companies by market capitalisation, at 649.01 Mn, behind Anteris Technologies Global Corp. at 837.13 Mn. The table below compares all 96 on 8 financial metrics.
| # | Ticker | Company | match | industry_code | industry_group | industry_group_code | Market Capitalization | P/E | P/S | Enterprise Value |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | IQV | Iqvia Holdings Inc. | primary | H-11 | Pharma Services | HG-03 | 42.35 Bn | 32.09 | 2.49 | 40.27 Bn |
| 2 | MEDP | Medpace Holdings, Inc. | primary | H-11 | Pharma Services | HG-03 | 16.32 Bn | 33.20 | 5.87 | 15.82 Bn |
| 3 | CRL | Charles River Laboratories International, Inc. | primary | H-11 | Pharma Services | HG-03 | 13.28 Bn | -55.86 | 3.32 | 13.09 Bn |
| 4 | ICLR | Icon Plc | primary | H-11 | Pharma Services | HG-03 | 12.47 Bn | 16.02 | 1.51 | 11.54 Bn |
| 5 | FTRE | Fortrea Holdings Inc. | primary | H-11 | Pharma Services | HG-03 | 1.59 Bn | -18.61 | 0.59 | 1.42 Bn |
| 6 | EVO | Evotec SE | primary | H-11 | Pharma Services | HG-03 | 0.65 Bn | — | — | 0.22 Bn |
| 7 | DNA | Ginkgo Bioworks Holdings, Inc. | primary | H-11 | Pharma Services | HG-03 | 0.42 Bn | -1.44 | 3.76 | 0.34 Bn |
| 8 | CSBR | Champions Oncology, Inc. | primary | H-11 | Pharma Services | HG-03 | 0.07 Bn | -58.86 | 1.16 | 0.07 Bn |
| 9 | HYFT | MindWalk Holdings Corp. | primary | H-11 | Pharma Services | HG-03 | 0.06 Bn | -5.75 | 5.27 | 0.05 Bn |
| 10 | VIVS | VivoSim Labs, INC. | primary | H-11 | Pharma Services | HG-03 | 0.00 Bn | -0.13 | 13.01 | 0.00 Bn |
| 11 | NOTVQ | Inotiv, Inc. | primary | H-11 | Pharma Services | HG-03 | 0.00 Bn | 0.00 | 0.00 | -0.01 Bn |
| 12 | TMO | Thermo Fisher Scientific Inc. | secondary | H-10 | Medical Devices and Diagnostics | HG-02 | 223.76 Bn | 31.78 | 4.83 | 219.69 Bn |
| 13 | PFE | Pfizer Inc | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 159.03 Bn | 36.41 | 2.50 | 147.33 Bn |
| 14 | TEVA | Teva Pharmaceutical Industries Ltd | secondary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 42.60 Bn | 61.21 | 2.46 | 38.95 Bn |
| 15 | ZTS | Zoetis Inc. | secondary | H-05 | Pharmaceuticals and Biotechnology | HG-01 | 30.66 Bn | 9.37 | 3.22 | 28.99 Bn |
| 16 | LH | Labcorp Holdings Inc. | secondary | H-17 | Healthcare Providers | HG-04 | 26.05 Bn | 25.95 | 1.82 | 25.90 Bn |
| 17 | WST | West Pharmaceutical Services Inc | secondary | H-07 | Medical Devices and Diagnostics | HG-02 | 23.90 Bn | 43.50 | 7.18 | 23.46 Bn |
| 18 | GH | Guardant Health, Inc. | secondary | H-17 | Healthcare Providers | HG-04 | 21.79 Bn | -48.05 | 18.41 | 20.73 Bn |
| 19 | IFF | International Flavors & Fragrances Inc | secondary | M-02 | Chemicals | MG-01 | 21.54 Bn | 73.76 | 2.16 | 20.97 Bn |
| 20 | STE | STERIS plc | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 21.09 Bn | 26.10 | 3.49 | 20.61 Bn |
| 21 | VTRS | Viatris Inc | secondary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 19.13 Bn | -46.58 | 1.30 | 18.24 Bn |
| 22 | LDOS | Leidos Holdings, Inc. | secondary | I-02 | Aerospace and Defense | IG-01 | 16.24 Bn | 11.64 | 0.92 | 15.49 Bn |
| 23 | DVA | Davita Inc. | secondary | H-14 | Healthcare Providers | HG-04 | 11.93 Bn | 10.25 | 0.85 | 11.24 Bn |
| 24 | TEM | Tempus AI, Inc. | secondary | H-17 | Healthcare Providers | HG-04 | 11.14 Bn | -44.84 | 7.78 | 10.33 Bn |
| 25 | PODD | Insulet Corp | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 9.87 Bn | 26.29 | 3.23 | 9.34 Bn |
| 26 | RDY | Dr Reddys Laboratories Ltd | secondary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 9.86 Bn | 781.50 | 2.69 | 9.69 Bn |
| 27 | IONS | Ionis Pharmaceuticals Inc | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 9.31 Bn | -43.86 | 10.65 | 7.25 Bn |
| 28 | TWST | Twist Bioscience Corp | secondary | H-10 | Medical Devices and Diagnostics | HG-02 | 7.79 Bn | -56.96 | 18.04 | 7.62 Bn |
| 29 | ALKS | Alkermes plc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 7.57 Bn | 114.42 | 4.54 | 6.91 Bn |
| 30 | GIFLF | Grifols SA | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 7.54 Bn | 29.70 | 0.46 | 9.09 Bn |
| 31 | CAI | Caris Life Sciences, Inc. | secondary | H-17 | Healthcare Providers | HG-04 | 6.90 Bn | 65.67 | 6.98 | 6.11 Bn |
| 32 | LNTH | Lantheus Holdings, Inc. | secondary | H-08 | Medical Devices and Diagnostics | HG-02 | 6.58 Bn | 23.89 | 4.23 | 5.98 Bn |
| 33 | LQDA | Liquidia Corp | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 6.09 Bn | 43.94 | 13.50 | 5.81 Bn |
| 34 | LGND | Ligand Pharmaceuticals Inc | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 5.82 Bn | 29.51 | 20.03 | 4.46 Bn |
| 35 | TLPPF | Telix Pharmaceuticals Ltd | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 3.89 Bn | -521.64 | 4.64 | 3.59 Bn |
| 36 | ADPT | Adaptive Biotechnologies Corp | secondary | H-17 | Healthcare Providers | HG-04 | 3.88 Bn | -96.43 | 12.60 | 3.54 Bn |
| 37 | OGN | Organon & Co. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 3.61 Bn | 17.25 | 0.59 | 2.47 Bn |
| 38 | ABCL | AbCellera Biologics Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 3.41 Bn | -20.72 | 51.55 | 3.41 Bn |
| 39 | BHC | Bausch Health Companies Inc. | secondary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 2.36 Bn | -2.16 | 0.22 | 0.52 Bn |
| 40 | NEO | Neogenomics Inc | secondary | H-17 | Healthcare Providers | HG-04 | 2.30 Bn | -44.24 | 3.00 | 2.15 Bn |
| 41 | ADMA | Adma Biologics, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 2.14 Bn | 12.86 | 4.17 | 2.00 Bn |
| 42 | NVAX | Novavax Inc | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.63 Bn | -6.58 | 3.94 | 0.91 Bn |
| 43 | SCNI | Scinai Immunotherapeutics Ltd. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.62 Bn | -192.89 | 938.23 | 1.61 Bn |
| 44 | IART | Integra Lifesciences Holdings Corp | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 1.24 Bn | -171.70 | 0.75 | 0.97 Bn |
| 45 | MGTX | MeiraGTx Holdings plc | secondary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 1.23 Bn | 7.48 | 3.08 | 1.09 Bn |
| 46 | MRVI | Maravai Lifesciences Holdings, Inc. | secondary | H-10 | Medical Devices and Diagnostics | HG-02 | 1.03 Bn | -7.56 | 4.93 | 0.96 Bn |
| 47 | AMPH | Amphastar Pharmaceuticals, Inc. | secondary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 0.99 Bn | 11.90 | 1.36 | 0.70 Bn |
| 48 | LXRX | Lexicon Pharmaceuticals, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.94 Bn | -15.00 | 22.74 | 0.75 Bn |
| 49 | QDEL | QuidelOrtho Corp | secondary | H-08 | Medical Devices and Diagnostics | HG-02 | 0.88 Bn | — | — | 0.75 Bn |
| 50 | AVR | Anteris Technologies Global Corp. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.84 Bn | -10.07 | 373.38 | 0.84 Bn |
| 51 | AQST | Aquestive Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.64 Bn | -8.16 | 11.81 | 0.54 Bn |
| 52 | OABI | OmniAb, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.52 Bn | -11.67 | 13.43 | 0.46 Bn |
| 53 | RGNX | REGENXBIO Inc. | secondary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.47 Bn | -2.66 | 2.49 | 0.37 Bn |
| 54 | CLPT | ClearPoint Neuro, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.42 Bn | -14.40 | 9.92 | 0.39 Bn |
| 55 | EYPT | EyePoint, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.39 Bn | -1.27 | 140.72 | 0.21 Bn |
| 56 | WDH | Waterdrop Inc. | secondary | F-16 | Insurance | FG-04 | 0.37 Bn | 4.73 | 0.50 | 0.19 Bn |
| 57 | STRO | Sutro Biopharma, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.31 Bn | -2.70 | 3.42 | 0.14 Bn |
| 58 | EMBC | Embecta Corp. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.30 Bn | 3.46 | 0.30 | 0.08 Bn |
| 59 | IMRX | Immuneering Corp | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.30 Bn | -5.15 | — | 0.30 Bn |
| 60 | EBS | Emergent BioSolutions Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.29 Bn | -1.66 | 0.38 | 0.15 Bn |
| 61 | BDSX | Biodesix Inc | secondary | H-17 | Healthcare Providers | HG-04 | 0.28 Bn | -9.82 | 2.74 | 0.25 Bn |
| 62 | MGNX | Macrogenics Inc | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.26 Bn | -16.14 | 1.55 | 0.15 Bn |
| 63 | OSUR | Orasure Technologies Inc | secondary | H-08 | Medical Devices and Diagnostics | HG-02 | 0.25 Bn | — | 2,471.19 | 0.05 Bn |
| 64 | UTMD | Utah Medical Products Inc | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.22 Bn | 22.57 | 6.17 | 0.14 Bn |
| 65 | AGPU | Axe Compute Inc. | secondary | T-44 | Cloud Computing | TG-07 | 0.22 Bn | -8.82 | — | 0.20 Bn |
| 66 | XGN | Exagen Inc. | secondary | H-17 | Healthcare Providers | HG-04 | 0.18 Bn | -9.37 | 2.49 | 0.15 Bn |
| 67 | IMDX | Insight Molecular Diagnostics Inc. | secondary | H-08 | Medical Devices and Diagnostics | HG-02 | 0.15 Bn | -2.81 | 91.43 | 0.13 Bn |
| 68 | KRMD | KORU Medical Systems, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.15 Bn | -61.85 | 3.22 | 0.14 Bn |
| 69 | MXCT | Maxcyte, Inc. | secondary | H-10 | Medical Devices and Diagnostics | HG-02 | 0.13 Bn | -3.73 | 4.28 | 0.13 Bn |
| 70 | APYX | Apyx Medical Corp | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.13 Bn | -15.31 | 2.26 | 0.10 Bn |
| 71 | CDXS | Codexis, Inc. | secondary | H-10 | Medical Devices and Diagnostics | HG-02 | 0.13 Bn | -4.22 | 1.67 | 0.07 Bn |
| 72 | BNR | Burning Rock Biotech Ltd | secondary | H-17 | Healthcare Providers | HG-04 | 0.10 Bn | -12.45 | 1.37 | 0.04 Bn |
| 73 | PTHS | Pelthos Therapeutics Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.08 Bn | -0.76 | 1.56 | 0.06 Bn |
| 74 | NTRB | NutriBand Inc. | secondary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 0.07 Bn | -10.28 | 44.26 | 0.07 Bn |
| 75 | XBIT | XBiotech Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.07 Bn | -1.61 | — | 0.07 Bn |
| 76 | CELU | Celularity Inc | secondary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.04 Bn | -0.41 | 1.43 | 0.03 Bn |
| 77 | SCLX | Scilex Holding Co | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.04 Bn | -0.08 | 1.18 | -0.08 Bn |
| 78 | NSYS | Nortech Systems Inc | secondary | I-04 | Machinery | IG-02 | 0.03 Bn | 12.07 | 0.37 | 0.03 Bn |
| 79 | BHST | Bioharvest Sciences Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.03 Bn | -3.09 | 0.93 | 0.02 Bn |
| 80 | LASE | Laser Photonics Corp | secondary | I-04 | Machinery | IG-02 | 0.03 Bn | -0.89 | 5.23 | 0.03 Bn |
| 81 | YDESW | YD Bio Ltd | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.03 Bn | — | — | 0.03 Bn |
| 82 | ABVC | Abvc Biopharma, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.03 Bn | -3.65 | — | 0.03 Bn |
| 83 | LGVN | Longeveron Inc. | secondary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.02 Bn | -0.89 | 17.63 | 0.01 Bn |
| 84 | COSM | Cosmos Health Inc. | secondary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 0.02 Bn | -0.78 | 0.22 | 0.01 Bn |
| 85 | PBSV | Pharma-Bio Serv, Inc. | secondary | I-26 | Business Services | IG-06 | 0.01 Bn | 238.12 | 1.36 | 0.00 Bn |
| 86 | NAII | Natural Alternatives International Inc | secondary | H-12 | Pharma Services | HG-03 | 0.01 Bn | -0.84 | 0.09 | 0.00 Bn |
| 87 | PLUR | Pluri Inc. | secondary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.01 Bn | 0.00 | 8.64 | 0.00 Bn |
| 88 | GELS | Gelteq Ltd | secondary | H-12 | Pharma Services | HG-03 | 0.01 Bn | — | — | 0.01 Bn |
| 89 | DQWS | DSwiss Inc | secondary | S-11 | Household and Personal Products | SG-05 | 0.01 Bn | -27.32 | 4.18 | 0.01 Bn |
| 90 | AIDX | 20/20 Biolabs, Inc. | secondary | H-17 | Healthcare Providers | HG-04 | 0.01 Bn | -0.94 | 2.80 | 0.00 Bn |
| 91 | CLGN | CollPlant Biotechnologies Ltd | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -0.64 | 10.92 | 0.00 Bn |
| 92 | STLNW | Starling Oncology, Inc. | secondary | H-14 | Healthcare Providers | HG-04 | 0.00 Bn | -0.14 | 0.01 | -0.04 Bn |
| 93 | BFRGW | BullFrog AI Holdings, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -0.31 | 5.53 | -0.01 Bn |
| 94 | SKVI | Skinvisible, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -1.05 | 54.04 | 0.00 Bn |
| 95 | CPMV | Mosaic ImmunoEngineering Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -0.64 | — | 0.00 Bn |
| 96 | NXGLW | Nexgel, Inc. | secondary | H-12 | Pharma Services | HG-03 | 0.00 Bn | -0.02 | 0.01 | 0.00 Bn |